Many dental implant companies in the United States are looking to increase their share of the growing market. In fact, there are over 35 competitors vying for a position in this $1.1 billion+ U.S. market.
We have also considered the impact of COVID-19 on the U.S. Dental Implant and Final Abutment market to create a full picture of the industry and using different scenarios, to estimate future demand for the markets under the scope of this analysis.
Navigating through this industry can be challenging, so we have compiled a list of outlining top dental implant companies to help you make better strategic decisions.
Top Dental Companies in the U.S.
- Dentsply Sirona
- Zimmer Biomet
- Osstem Implant (HIOSSEN)
- ACE Surgical
- Henry Schein
Straumann replaced Envista in 2019 as the leader of the overall dental implant market and remained the leader in 2020. The Swiss company develops dental implants, biomaterials, and instruments for dental procedures. In addition, Straumann also provides a wide range of services to dental practitioners around the globe, such as dental lab finder, and its marketing toolbox.
By pursuing an ambitious acquisition strategy, Straumann managed to obtain a great presence in the U.S. dental market. For instance, in 2017, the company acquired a leading provider of digital dentistry, Dental Wings. This acquisition has helped the company gain access to a large customer base for dental implants. Dental Wings’ CoDiagnostiX™ software has grown in popularity, and by 2018 the company held a notable share of the treatment planning software market.
Based on our market analysis, Straumann has performed considerably well in the U.S. dental implant fixture, final abutment and instrument kits markets. It also managed to acquire a small market share of the treatment planning software and surgical guides segments. Financial reports from the second quarter of 2020 indicated that Straumann was weathering the COVID-19 crisis better than its competitors. Looking to the future, Straumann is in a good position to recover quickly and maintain its market presence.
Envista is the parent company of Nobel Biocare, Implant Direct, KaVo Kerr and other dental equipment and consumables brands. The company currently ranks as second-leading competitor in the total dental implant market. In 2019, Envista went public on the NYSE, using the funds raised in its initial public offering (IPO) to to purchase its constituent companies from Danaher, completing the separation of the two companies.
The Nobel Biocare brand drives the company’s strong presence in the premium dental implant segment, despite challenges stemming from COVID-19. The pricing of Envista’s Nobel Biocare branded products places it firmly in the premium segment, though the company’s premium implants are priced slightly below Straumann’s.
Envista is also a major player in the value implant segment under its Implant Direct brand. Market trends towards value and discounted implants have favored Implant Direct, but the company’s lower prices limit the company’s total revenue.
3. Dentsply Sirona
The third leading competitor in the U.S. dental implant market is Dentsply Sirona. In contrast to Straumann and Med Biocare, it is a US-based company that offers a comprehensive line of dental implants, materials, surgery instruments, and various restorative solutions. In an overview of the global dental implants industry, Dentsply Sirona ranks among the top competitors in 6 out of 9 dental markets.
In the last decade, Dentsply Sirona went through great deal mergers and acquisitions in order to acquire its strong market positioning. For instance, in 2016, Dentsply Sirona acquired MIS Implants, an Israeli company with a leading position in the value implant segment. The company’s decision was driven by the growing popularity of the value implant segment.
Thus, to a premium implant company, such as Dentsply Sirona, this acquisition provided a foothold in the value dental implant market. As the industry reels from the impacts of COVID-19, Dentsply Sirona is also adjusting its corporate strategy to minimize inefficiencies, cut costs and exit underperforming markets.
Similar to Zimmer Biomet, BioHorizons held a little over 8% of the overall dental implant market in 2020. Because the implant market is largely dominated by premium products, BioHorizons’ share in the value segment translates into a smaller portion of the overall U.S. implant market.
However, the company’s higher price point, relative to other value implant brands, has contributed to its leading revenue share. Moreover, as the value segment is expected to demonstrate relatively high growth, BioHorizons is expected to experience significant growth in terms of future sales.
5. Zimmer Biomet
Zimmer Biomet is the fifth strong player in the dental implant market. In 2015, it was born as a result of a merger between two US-based medical device companies, Zimmer Inc. and Biomet Inc. As of 2020, the company’s dental implant market share was approximately 8%.
Zimmer Biomet’s main portfolio of implant systems includes the T3®, 3.1mmD Eztetic™, Tapered Screw Vent®, OSSEOTITE®, Trabecular Metal™ and LOCATOR® Overdenture Dental Implants System. In addition to its implant products, Zimmer Biomet carries a complete product line, including bone regeneration products, computer-guided surgery solutions and digital dentistry solutions through its Zfx™ brand.
6. Osstem Implant (HIOSSEN)
HIOSSEN was the sixth-leading competitor in the dental implant and final abutment market in 2020. It was founded in 2006 and is the North American subsidiary of a bigger corporation, Osstem Implant. Similar to the rest of the companies on the list, HIOSSEN manufactures dental implants, biomaterial and different solutions for dental surgery procedures.
Osstem Implant, however, is the leading dental implant manufacturer in the South Korean and Asia-Pacific markets. Thus, HIOSSEN is Osstem Implant’s way of having its foot in the U.S. market.
7. ACE Surgical
ACE Surgical maintains a modest share of the overall U.S. dental implant market and occupies the seventh spot on our list. The company has a strong product suite in the value and mini implant segments. It’s Infinity family of implant fixtures managed to become its most profitable implant offerings, covering a variety of shapes and sizes. However, the industry has thus far been reluctant to adopt mini implant products and ACE Surgical is likely to see slow growth in this segment.
The eighth spot on our list belongs to MegaGen, an Asian-born company that also aims for a share of the dental implant space in the USA. After separating from one of the bigger players, Straumann Group, it developed its own global market strategy and became an independent dental solutions provider.
While the company has been a top contender in its domestic South Korean market for many years, where its implants are used in more than 6,000 procedures per month, it has recently begun to experience significant growth and increased adoption in the U.S.
Bicon is one of the many value implant providers, ranking number 8 in our list. It is a US privately-owned company, and it is commonly known for its specialty implants. Over the years, Bicon acquired a loyal implant user base because its implants are simple, user-friendly and are offered at a decent price. Customers have also remained committed to Bicon implants because clinical studies performed on the company’s products have proved that they are reliable and yield positive outcomes for its users.
10. Henry Schein
Henry Schein is the company that closes our list of top dental implant companies in the USA. It is a global dental and medical equipment distributor and the parent company of popular brands, including CAMLOG and Intra-Lock. In 2018, Henry Schein announced its acquisition of Intra-Lock, a dental implant company based in Boca Raton, Florida. Intra-Lock is the leading player in the mini implant market. ACE Surgical and BioHorizons are independently operated subsidiaries of Henry Schein.
The US dental implant market is expected to grow at a 7.8% CAGR for the next few years. While the premium implant companies, such as Straumann, Nobel Bionics, and Dentsply Sirona, control a large portion of the market, value-based and discount companies have seen a rise in popularity. By recognizing this shift towards more affordable implant offerings, premium companies are pressured to acquire smaller value-based implant business. As a result, the average selling prices of dental implants have been in decline.
The dental implant market experienced a considerable drop in 2020, due to COVID-19, but showed promising signs of a strong recovery heading into Q3. The market has yet to reach its full potential, as only a minority of those suffering from tooth loss opt for a dental implant.